We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Endoscopic Sinus Surgery Improves Sufferers Quality of Life

By HospiMedica International staff writers
Posted on 18 Jan 2010
Over three-quarters of patients with chronic rhinosinusitis (CRS) experienced significant quality of life (QOL) improvements after undergoing endoscopic sinus surgery (ESS), according to a new study.

Researchers at the Oregon Health and Science University (OHSU; Portland, USA), Stanford University Medical Center (SUMC; CA, USA; stanfordhospital.org), and other institutions conducted a prospective, multi-institutional cohort study that analyzed a total 302 patients with CRS from three medical centers between July 2004 and December 2008, and followed the patients for approximately one and a half years postoperatively. More...
Computerized tomography (CT) scan, endoscopy score, and pre- and postoperative quality of life (QOL) data were collected. In addition, preoperative patient factors were evaluated for their ability to predict clinically significant outcomes so that surgeons could appropriately counsel patients and optimize surgical case selection.

The results of the study showed 72% to 76% of patients with CRS and poor baseline QOL, experienced clinically significant improvement in disease-specific QOL outcomes after ESS. Clinical factors, including asthma, aspirin intolerance, and prior sinus surgery, as well as preoperative diagnostic testing were found to be important potential predictors of outcomes. However, few of these variables were found to be significant predictors of improvement when multiple risk factors were accounted for in the predictive model. In all, primary ESS patients were twice as likely to improve after surgery as patients undergoing revision ESS. The study was published in the January 2010 issue of Otolaryngology - Head and Neck Surgery.

"These were patients who have chronic sinusitis so, by definition, they have at least three months of symptoms and they have evidence of an ongoing inflammation or infection of their nose and sinuses on either a CT scan or an examination of the nose and sinuses,” said lead author Timothy Smith, M.D., M.P.H., of OHSU. "Following the surgery, about 76% of patients had clinically significant improvement in quality of life.”

CRS is a debilitating form of sinusitis that affects 14-16% percent of the U.S. population, and can lead to significant physical symptoms, as well as substantial functional and emotional impairment. Symptoms of CRS include stuffy nose, sinus pain and pressure, headache, and sneezing. Consequently, CRS is often confused with the cold, flu, or allergies. Due to the chronic nature of the disease, and the relatively poor response of some patients to initial medical therapies, patients with CRS undergo 500,000 surgical procedures annually in the United States alone, with the primary goal of improving QOL.

Related Links:
Oregon Health and Science University
Stanford University Medical Center



Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Adjustable Mobile Barrier
M-458
Electric Bed
DIXION Intensive Care Bed
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.